GlycoMimetics Offers Data on GMI-1271 Treatment of Acetaminphen-Triggered Liver Toxicity at Conference
April 25, 2016 at 16:32 PM EDT
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that collaborative research on the effects of its clinical drug candidate GMI-1271 on ...
